Different methods of eubiotic feed additive provision affect the health, performance, fermentation, and metabolic status of dairy calves during the preweaning period.


Journal

BMC veterinary research
ISSN: 1746-6148
Titre abrégé: BMC Vet Res
Pays: England
ID NLM: 101249759

Informations de publication

Date de publication:
12 Apr 2022
Historique:
received: 28 07 2021
accepted: 05 04 2022
entrez: 13 4 2022
pubmed: 14 4 2022
medline: 15 4 2022
Statut: epublish

Résumé

This study aimed to evaluate whether different methods of providing eubiotic feed additives to neonatal calves, during the preweaning period, can improve the calves' health, performance, ruminal fermentation, and metabolic status. Forty-four (3-day-old) Holstein-Friesian dairy calves (22 female and 22 male) were divided into four treatment groups for the duration of the 8-week trial. The eubiotic feed additive consisted of a combination of probiotic Lactobacillus spp. (multiple-strains at a dose of 250 mg/calf/day) and phytobiotics containing rosmarinic acid, as the main bioactive compound (at a dose of 50 mg/calf/day). The groups were named: CON (control, without eubiotic in either the milk replacer or the starter feed), MR (eubiotic in the milk replacer), SF (eubiotic in the starter feed), MRS (eubiotic in both the milk replacer and the starter feed). The individual intake of starter feed and the fecal scores were measured daily, and body weight and biometric measurements were taken weekly until calves were 56 days of age. Blood samples were collected on day 3 and then every 14 days to determine concentrations of insulin-like-growth-factor-I, β-hydroxybutyrate, non-esterified fatty acids, and blood urea nitrogen. Ruminal fluid was collected on days 28 and 56 for short-chain fatty acids, NH The body weight of the calves of the MR treatment group was higher compared to all other groups on days 28 and 56. Including the eubiotic feed additive in the milk replacer increased average daily gain, starter intake, and total dry matter intake from day 29 to day 56 and the overall experimental period compared to the CON group. The calves with MR treatment had lower fecal scores from days 3 to 28, a number of parasite oocysts/cysts per gram of feces on day 28, and the occurrences of fecal consistency scores of 3 (mild diarrhea) and 4 (severe diarrhea) were 3.2 and 3.0 times lower, respectively, compared with the CON group. The MR group had higher ruminal concentrations of short-chain-fatty-acids, propionate, and butyrate on day 56 than the CON group. Adding eubiotics into milk replacer resulted in the highest concentrations of blood insulin-like-growth-factor-I and β-hydroxybutyrate from days 29 to 56 and the overall experimental period. The addition of eubiotic feed additives into the milk replacer can improve health, performance, ruminal fermentation, and biochemical blood indices in dairy calves during the preweaning period.

Sections du résumé

BACKGROUND BACKGROUND
This study aimed to evaluate whether different methods of providing eubiotic feed additives to neonatal calves, during the preweaning period, can improve the calves' health, performance, ruminal fermentation, and metabolic status. Forty-four (3-day-old) Holstein-Friesian dairy calves (22 female and 22 male) were divided into four treatment groups for the duration of the 8-week trial. The eubiotic feed additive consisted of a combination of probiotic Lactobacillus spp. (multiple-strains at a dose of 250 mg/calf/day) and phytobiotics containing rosmarinic acid, as the main bioactive compound (at a dose of 50 mg/calf/day). The groups were named: CON (control, without eubiotic in either the milk replacer or the starter feed), MR (eubiotic in the milk replacer), SF (eubiotic in the starter feed), MRS (eubiotic in both the milk replacer and the starter feed). The individual intake of starter feed and the fecal scores were measured daily, and body weight and biometric measurements were taken weekly until calves were 56 days of age. Blood samples were collected on day 3 and then every 14 days to determine concentrations of insulin-like-growth-factor-I, β-hydroxybutyrate, non-esterified fatty acids, and blood urea nitrogen. Ruminal fluid was collected on days 28 and 56 for short-chain fatty acids, NH
RESULTS RESULTS
The body weight of the calves of the MR treatment group was higher compared to all other groups on days 28 and 56. Including the eubiotic feed additive in the milk replacer increased average daily gain, starter intake, and total dry matter intake from day 29 to day 56 and the overall experimental period compared to the CON group. The calves with MR treatment had lower fecal scores from days 3 to 28, a number of parasite oocysts/cysts per gram of feces on day 28, and the occurrences of fecal consistency scores of 3 (mild diarrhea) and 4 (severe diarrhea) were 3.2 and 3.0 times lower, respectively, compared with the CON group. The MR group had higher ruminal concentrations of short-chain-fatty-acids, propionate, and butyrate on day 56 than the CON group. Adding eubiotics into milk replacer resulted in the highest concentrations of blood insulin-like-growth-factor-I and β-hydroxybutyrate from days 29 to 56 and the overall experimental period.
CONCLUSION CONCLUSIONS
The addition of eubiotic feed additives into the milk replacer can improve health, performance, ruminal fermentation, and biochemical blood indices in dairy calves during the preweaning period.

Identifiants

pubmed: 35413974
doi: 10.1186/s12917-022-03239-y
pii: 10.1186/s12917-022-03239-y
pmc: PMC9003169
doi:

Substances chimiques

Fatty Acids, Volatile 0
Insulin 0
3-Hydroxybutyric Acid TZP1275679

Types de publication

Journal Article Randomized Controlled Trial, Veterinary

Langues

eng

Sous-ensembles de citation

IM

Pagination

138

Subventions

Organisme : This study was supported by grant financed by The National Centre for Research and Development: Warszawa; Poland
ID : grant no. PBS1/A8/10/2012
Organisme : This study was supported by grant financed by The National Centre for Research and Development: Warszawa; Poland
ID : grant no. PBS1/A8/10/2012
Organisme : This study was supported by grant financed by The National Centre for Research and Development: Warszawa; Poland
ID : grant no. PBS1/A8/10/2012

Informations de copyright

© 2022. The Author(s).

Références

J Dairy Sci. 2011 Jun;94(6):3002-13
pubmed: 21605770
J Dairy Sci. 2018 Feb;101(2):1661-1672
pubmed: 29248211
J Dairy Sci. 2018 May;101(5):4473-4478
pubmed: 29501344
J Dairy Sci. 2017 Jan;100(1):1-16
pubmed: 28341041
J Dairy Sci. 2015 Sep;98(9):6315-26
pubmed: 26142851
J Dairy Sci. 2007 Nov;90(11):5259-68
pubmed: 17954766
Asian-Australas J Anim Sci. 2013 Jul;26(7):935-44
pubmed: 25049871
J Dairy Sci. 2020 Mar;103(3):2315-2323
pubmed: 31980222
J Dairy Sci. 2021 Feb;104(2):1645-1659
pubmed: 33309369
J Dairy Sci. 2005 Jun;88(6):2154-65
pubmed: 15905445
J Anim Physiol Anim Nutr (Berl). 2022 Jan;106(1):33-44
pubmed: 34060144
J Dairy Sci. 2020 Apr;103(4):3882-3893
pubmed: 32037167
J Dairy Sci. 2018 Oct;101(10):9229-9244
pubmed: 29935825
J Dairy Sci. 2017 Jul;100(7):5984-5995
pubmed: 28527800
Animal. 2015 Jun;9(6):958-65
pubmed: 25690024
Animal. 2020 Oct;14(10):2054-2062
pubmed: 32308189
J Dairy Sci. 1991 Oct;74(10):3583-97
pubmed: 1660498
J Dairy Sci. 1992 Jan;75(1):228-35
pubmed: 1541733
Vet Immunol Immunopathol. 2019 Feb;208:58-66
pubmed: 30712793
J Dairy Sci. 2019 Jul;102(7):6404-6417
pubmed: 31056325
Curr Res Parasitol Vector Borne Dis. 2021;1:None
pubmed: 35005687
J Dairy Sci. 2010 Aug;93(8):3713-21
pubmed: 20655440
J Dairy Sci. 2019 May;102(5):4498-4505
pubmed: 30852016
Microbes Environ. 2015;30(2):126-32
pubmed: 26004794
J Dairy Sci. 2012 Feb;95(2):783-93
pubmed: 22281343
Animal. 2020 Mar;14(S1):s133-s143
pubmed: 32024575
J Dairy Sci. 2021 Aug;104(8):9037-9051
pubmed: 33985777
J Dairy Sci. 2012 May;95(5):2585-94
pubmed: 22541487
J Dairy Sci. 2008 Apr;91(4):1497-509
pubmed: 18349243
Endocr Rev. 1995 Feb;16(1):3-34
pubmed: 7758431
Proc Natl Acad Sci U S A. 2015 May 5;112(18):5649-54
pubmed: 25792457
J Dairy Sci. 2020 Apr;103(4):3828-3837
pubmed: 32037180
Sci Total Environ. 2016 Mar 1;545-546:556-68
pubmed: 26760275
J Anim Sci. 2017 Aug;95(8):3772-3782
pubmed: 28805907
J Anim Sci. 1997 May;75(5):1244-55
pubmed: 9159271
J Dairy Sci. 1991 Jan;74(1):250-7
pubmed: 2030170
PLoS One. 2021 Mar 11;16(3):e0231068
pubmed: 33705410
J Dairy Sci. 2012 Sep;95(9):5292-5298
pubmed: 22916934
Int J Food Microbiol. 2004 Aug 1;94(3):223-53
pubmed: 15246235
Poult Sci. 2004 Feb;83(2):169-74
pubmed: 14979566
Appl Environ Microbiol. 2011 Feb;77(4):1335-43
pubmed: 21169430

Auteurs

Barbara Stefańska (B)

Department of Grassland and Natural Landscape Sciences, Poznań University of Life Sciences, Poznań, Poland. barbara.stefanska@up.poznan.pl.

Frank Katzer (F)

Department of Disease Control, Moredun Research Institute, Penicuik, UK.

Barbara Golińska (B)

Department of Grassland and Natural Landscape Sciences, Poznań University of Life Sciences, Poznań, Poland.

Patrycja Sobolewska (P)

Department of Grassland and Natural Landscape Sciences, Poznań University of Life Sciences, Poznań, Poland.

Sebastian Smulski (S)

Department of Internal Diseases and Diagnostics, Poznań University of Life Sciences, Poznań, Poland.

Andrzej Frankiewicz (A)

Department of Animal Nutrition, Poznań University of Life Sciences, Poznań, Poland.

Włodzimierz Nowak (W)

Department of Animal Nutrition, Poznań University of Life Sciences, Poznań, Poland.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH